You are here:
22 December 2011
GAVI appreciation for FY2012 appropriations passed by US Congress
GAVI Alliance expresses its deep appreciation for an increase in funding secured in the Fiscal Year 2012 omnibus spending bill passed by the US Congress on 17 December.
01 December 2011
GAVI role in achieving world free from AIDS
CEO Seth Berkley says that GAVI stands ready to play its role in achieving a world with zero new HIV infections and zero AID-s related deaths.
25 October 2011
Rotavirus deaths remain unacceptably high
Rotavirus-related diarrhoea kills
mostly in developing countries, but vaccine roll outs have begun.
24 October 2011
Polio eradication will highlight the power of immunisation
Feared for centuries because of the death
and paralysis it causes, polio is finally on the edge of eradication.
19 October 2011
GAVI lifts suspension of its cash support to Mali
The Malian Government has fully reimbursed GAVI the amount of US$ 563,000 that was misused during the period 2008-2010.
18 October 2011
New promise of a malaria vaccine
New results published today in the New England Journal of Medicine about a large-scale Phase III trial conducted in seven African countries of the malaria vaccine candidate RTS,S deserve a hearty round of applause.
07 October 2011
GAVI congratulates Nobel Peace Prize winner
The GAVI Alliance congratulates Liberian President Ellen Johnson Sirleaf on winning the Nobel Peace Prize.
21 September 2011
On Tuesday 27 September, the GAVI Alliance will make a major announcement about vaccines to protect children in Africa and other developing countries against diarrhoea and pneumonia.
15 September 2011
GAVI welcomes new data on falling child mortality
UN Inter-agency report says prioritisation needed on tackling major killers of children such as pneumonia and diarrhoea
17 August 2011
Panacea Biotec “Easyfive” pentavalent vaccine loses WHO prequalification
GAVI Alliance partners do not expect any major disruption in 2011 to supplies of pentavalent vaccines following today’s announcement by the World Health Organization (WHO) that it has delisted “Easyfive,” a pentavalent vaccine produced by Panacea Biotec.
© Gavi 2014
modal window here